Search - tctmd.com

Displaying 1 - 20 of 137

Sort: Relevancy | Date

News Daily News

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Yael L. Maxwell

June 09, 2025

News Conference News EuroPCR 2025

Short DAPT in High-Bleeding-Risk Patients Reduces Recurrent Events: MASTER DAPT

Yael L. Maxwell

May 23, 2025

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

Presentation TCT 2024

TCT 173: Contemporary Risk Prediction and Stratification of Long-Term Major Adverse Cardiac and Cerebrovascular Events After Percutaneous Coronary Intervention: The REMEDY Score

Presenter: Jiaxi Cheng

October 28, 2024

News Daily News

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

L.A. McKeown

October 23, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Daily News

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

Michael O'Riordan

June 21, 2024

News Daily News

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

Yael L. Maxwell

May 03, 2024

News Conference News ACC 2024

ULTIMATE-DAPT: Another Boost for Solo Ticagrelor 1 Month After ACS PCI

Yael L. Maxwell

April 07, 2024

News Daily News

No Benefit to P2Y12 Inhibitor Pretreatment in STEMI, Bern-PCI Data Confirm

Yael L. Maxwell

January 10, 2024

News Daily News

Adherence Key to CPAP’s Benefits in Sleep Apnea Patients With CVD

Caitlin E. Cox

October 04, 2023

News Daily News

Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival

L.A. McKeown

September 14, 2023

News Daily News

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

Michael O'Riordan

September 13, 2023

News Daily News

Study Finds No Increased Risk of CVD Years After Infertility Therapies

L.A. McKeown

August 11, 2023

News Daily News

Surgeons Say ACC/AHA Chronic Coronary Disease Guidelines Whiffed

Michael O'Riordan

August 03, 2023

News Daily News

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Michael O'Riordan

May 03, 2023

News Daily News

Severe Infections Linked to a Variety of CV Events, Both Acute and Long-term

Caitlin E. Cox

March 28, 2023

News Conference News ACC 2023

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

Michael O'Riordan

March 06, 2023

News Daily News

CV Risk After Acute COVID-19 Not So High as Feared: Registry

Todd Neale

January 06, 2023

Advertisement

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Short DAPT in High-Bleeding-Risk Patients Reduces Recurrent Events: MASTER DAPT

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

TCT 173: Contemporary Risk Prediction and Stratification of Long-Term Major Adverse Cardiac and Cerebrovascular Events After Percutaneous Coronary Intervention: The REMEDY Score

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

September 2024 Dispatch for the CV Team

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

ULTIMATE-DAPT: Another Boost for Solo Ticagrelor 1 Month After ACS PCI

No Benefit to P2Y12 Inhibitor Pretreatment in STEMI, Bern-PCI Data Confirm

Adherence Key to CPAP’s Benefits in Sleep Apnea Patients With CVD

Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

Study Finds No Increased Risk of CVD Years After Infertility Therapies

Surgeons Say ACC/AHA Chronic Coronary Disease Guidelines Whiffed

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Severe Infections Linked to a Variety of CV Events, Both Acute and Long-term

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

CV Risk After Acute COVID-19 Not So High as Feared: Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content